Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis - Liu, Wei-Ren; Tian, Meng-Xin; Tao, Chen-Yang; Tang, Zheng; Zhou, Yu-Fu; Song, Shu-Shu; Jiang, Xi-Fei; Wang, Han; Zhou, Pei-Yun; Qu, Wei-Feng; Fang, Yuan; Ding, Zhen-Bin; et al. (BMC cancer, 2020)
Keywords: Alanine; Alanine transaminase; Analysis; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Bile Duct Neoplasms - mortality; Bile Duct Neoplasms - pathology; Bile Duct Neoplasms - therapy; Biliary tract cancer; Cancer metastasis; Carcinoma, Hepatocellular - mortality; Carcinoma, Hepatocellular - pathology; Carcinoma, Hepatocellular - therapy; Care and treatment; Chemoembolization; Chemoembolization, Therapeutic - mortality; Chemotherapy, Adjuvant; Cholangiocarcinoma; Cholangiocarcinoma - mortality; Cholangiocarcinoma - pathology; Cholangiocarcinoma - therapy; Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma; Combined Modality Therapy; Disease-free survival; Female; Follow-Up Studies; Hepatectomy - mortality; Hepatocellular carcinoma; Humans; Liver cancer; Liver Neoplasms - mortality; Liver Neoplasms - pathology; Liver Neoplasms - therapy; Lymphatic system; Male; Medical prognosis; Medical research; Metastases; Metastasis; Middle Aged; Neoplasm Recurrence, Local - mortality; Neoplasm Recurrence, Local - pathology; Neoplasm Recurrence, Local - therapy; Overall survival; Patient outcomes; Prognosis; Propensity score matching analysis; Regression analysis; Retrospective Studies; Surgery; Survival; Survival Rate; Transarterial chemoembolization; Transplants & implants; Tumors; Veins & arteries; γ-Glutamyltransferase; United States--US; Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma; Overall survival; Propensity score matching analysis; Transarterial chemoembolization; Disease-free survival